◀ Back to MAP2K1
MAP2K1 — MAP3K8
Pathways - manually collected, often from reviews:
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Hagemann et al., Oncogene 1999
:
Wildtype and activated
Cot phosphorylate and
activate MEK-1 and SEK-1 in vitro
Tu et al., Cell Signal 2003
:
They consist of a three-kinase module in which a mitogen activated protein kinase kinase kinase (
MAP3K )
activates a
mitogen activated protein kinase kinase ( MAP2K ), which in turn activates MAPK
Huang et al., Biochem Biophys Res Commun 2003
:
MAP3Ks are components of a three tiered protein kinase pathway in which a
MAP3K phosphorylates and
activates a
mitogen activated protein kinase kinase ( MAP2K ), which in turn activates a mitogen activated protein kinase ( MAPK )
López-Pelaéz et al., Mol Biol Cell 2012
(Inflammation...) :
Cot/tpl2 is the only
MAP3K that
activates MKK1/2-Erk1/2 in Toll-like receptor activated macrophages
Roget et al., Mol Cell Biol 2012
:
LPS stimulation of TPL-2
MEK-1/2 kinase activity
requires TPL-2 release from p105
Sanz-Garcia et al., J Biol Chem 2013
(Drug-Induced Liver Injury...) :
Cot/tpl2 ( MAP3K8 )
activates MKK1/2-Erk1/2 following stimulation of the Toll-like/IL-1 receptor superfamily
Tsatsanis et al., Oncogene 1998
(Lymphoma, T-Cell) :
Since the activation of NFAT is MAPK dependent these findings suggested that the activation of MAPK by
Tpl-2 is either independent or only partially
dependent on
MEK1 and MEK2